> Details

Allen, Scott P.; Al Sultan, Afnan; Kabucho Kibirige, Elaine; Tonkiss, Erin; Hamer, Keaton J.; Castelli, Lydia M.; Lin, Ya-Hui; Roscoe, Sarah; Stefanidis, Nikolaos; Mead, Richard J.; Highley, J. Robin; Cooper-Knock, Johnathan; Hautbergue, Guillaume M.; Heath, Paul R.; Kirby, Janine; Shaw, Pamela J.

A Y374X TDP43 truncation leads to an altered metabolic profile in amyotrophic lateral sclerosis fibroblasts driven by pyruvate and TCA cycle intermediate alterations

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: A Y374X TDP43 truncation leads to an altered metabolic profile in amyotrophic lateral sclerosis fibroblasts driven by pyruvate and TCA cycle intermediate alterations
  • Contributor: Allen, Scott P.; Al Sultan, Afnan; Kabucho Kibirige, Elaine; Tonkiss, Erin; Hamer, Keaton J.; Castelli, Lydia M.; Lin, Ya-Hui; Roscoe, Sarah; Stefanidis, Nikolaos; Mead, Richard J.; Highley, J. Robin; Cooper-Knock, Johnathan; Hautbergue, Guillaume M.; Heath, Paul R.; Kirby, Janine; Shaw, Pamela J.
  • Published: Frontiers Media SA, 2023
  • Published in: Frontiers in Aging Neuroscience, 15 (2023)
  • Language: Not determined
  • DOI: 10.3389/fnagi.2023.1151848
  • ISSN: 1663-4365
  • Keywords: Cognitive Neuroscience ; Aging
  • Origination:
  • Footnote:
  • Description: A p.Y374X truncation in TARDBP was recently shown to reduce expression of TDP43 in fibroblasts isolated from ALS cases. In this follow up study focused on assessing the downstream phenotypic consequences of loss of TDP43 in the context of the truncation, we have shown a striking effect on the fibroblast metabolic profile. Phenotypic metabolic screening uncovered a distinct metabolic profile in TDP43-Y374X fibroblasts compared to controls, which was driven by alterations in key metabolic checkpoint intermediates including pyruvate, alpha-ketoglutarate and succinate. These metabolic alterations were confirmed using transcriptomics and bioenergetic flux analysis. These data suggest that TDP43 truncation directly compromises glycolytic and mitochondrial function, identifying potential therapeutic targets for mitigating the effects of TDP43-Y374X truncation.
  • Access State: Open Access